1. Aan Het Rot, M., Zarate, C. A., Charney, D. S., & Mathew, S. J. (2012). Ketamine for depression: Where do we go from here? Biological Psychiatry, 72(7), 537–547.
2. Aguayo, L. G., Warnick, J. E., Maayani, S., Glick, S. D., Weinstein, H., & Albuquerque, E. X. (1982). Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: Implications for behavioral effects. Molecular Pharmacology, 21(3), 637–647.
3. Andreasen, J. T., Gynther, M., Rygaard, A., Bogelund, T., Nielsen, S. D., Clausen, R. P., Mogensen, J., & Pickering, D. S. (2013). Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests. Neuroscience Letters, 546, 6–10.
4. Anon. (1979). The 1977 street drug analysis results: PharmChem research foundation. Clinical Toxicology, 14(5), 619–630.
5. Beardsley, P. M., & Balster, R. L. (1987). Behavioral dependence upon phencyclidine and ketamine in the rat. The Journal of Pharmacology and Experimental Therapeutics, 242(1), 203–211.